Advagene Biopharma (Taiwan) Buy Hold or Sell Recommendation
6709 Stock | TWD 26.75 8.45 46.17% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Advagene Biopharma Co is 'Strong Sell'. Macroaxis provides Advagene Biopharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 6709 positions. The advice algorithm takes into account all of Advagene Biopharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Advagene Biopharma's buy or sell advice are summarized below:
Real Value 16.63 | Hype Value 18.4 | Market Value 26.75 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Advagene Biopharma Co given historical horizon and risk tolerance towards Advagene Biopharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Advagene Biopharma Co, the advice is generated through an automated system that utilizes algorithms and statistical models.
Advagene |
Execute Advagene Biopharma Buy or Sell Advice
The Advagene recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Advagene Biopharma Co. Macroaxis does not own or have any residual interests in Advagene Biopharma Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Advagene Biopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Advagene Biopharma Trading Alerts and Improvement Suggestions
Advagene Biopharma generated a negative expected return over the last 90 days |
Advagene Biopharma Returns Distribution Density
The distribution of Advagene Biopharma's historical returns is an attempt to chart the uncertainty of Advagene Biopharma's future price movements. The chart of the probability distribution of Advagene Biopharma daily returns describes the distribution of returns around its average expected value. We use Advagene Biopharma Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Advagene Biopharma returns is essential to provide solid investment advice for Advagene Biopharma.
Mean Return | -0.49 | Value At Risk | -4.87 | Potential Upside | 3.05 | Standard Deviation | 2.38 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Advagene Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Advagene Biopharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Advagene Biopharma or Advagene sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Advagene Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Advagene stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.52 | |
β | Beta against NYSE Composite | 0.18 | |
σ | Overall volatility | 2.55 | |
Ir | Information ratio | -0.25 |
Advagene Biopharma Volatility Alert
Advagene Biopharma Co exhibits very low volatility with skewness of 0.33 and kurtosis of 2.12. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Advagene Biopharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Advagene Biopharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Advagene Biopharma Fundamentals Vs Peers
Comparing Advagene Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Advagene Biopharma's direct or indirect competition across all of the common fundamentals between Advagene Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Advagene Biopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Advagene Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Advagene Biopharma by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Advagene Biopharma to competition |
Fundamentals | Advagene Biopharma | Peer Average |
Number Of Employees | 10 | 18.84 K |
Market Capitalization | 879.46 M | 19.03 B |
Advagene Biopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Advagene . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Advagene Biopharma Buy or Sell Advice
When is the right time to buy or sell Advagene Biopharma Co? Buying financial instruments such as Advagene Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Advagene Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Real Estate Thematic Idea Now
Real Estate
Publicly traded companies that are involved in real estate development, property maintenance and management of real estate investment trusts (REIT) funds. The Real Estate theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.
View All Next | Launch |
Check out Advagene Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Advagene Stock analysis
When running Advagene Biopharma's price analysis, check to measure Advagene Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advagene Biopharma is operating at the current time. Most of Advagene Biopharma's value examination focuses on studying past and present price action to predict the probability of Advagene Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advagene Biopharma's price. Additionally, you may evaluate how the addition of Advagene Biopharma to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |